Stock screenerAll disclosures →
EDGAR →
LXRX
Conviction 100HealthcareScan · Mon, Aug 10, 2026LXRX$2.40-2.83%
ResistanceSupportVol 14Vol MA14 3.85M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price2.40
Change-2.83%
Gap-0.40%
Rel volume5.08×
Avg volume3.52M
Avg $ vol8.26M
SMA 202.33
SMA 502.21
SMA 2001.70
Price vs 50+8.68%
Price vs 200+41.15%
MA stackbullish
50/200 cross—
Supertrenddown · 2.55
RSI (14)55
MACD hist0.01
MACD crossbull · 4d
Stoch %K / %D79 / 80
ADX (14)16
+DI / −DI16 / 26
RSI divergence—
MACD divergence—
ATR %+6.88%
ADR %7.00%
52w high2.64
52w low1.04
From 52w high-9.09%
Above 52w low+130.77%
New 52w highNo
SqueezeOn · 10d
Bollinger width15.38%
%B0.70
Donchian pos78.57%
Donchian high2.52
Donchian low1.96
AVWAP (52w high)2.33
vs AVWAP high+2.93%
AVWAP (52w low)1.72
vs AVWAP low+39.49%
OBV trendDown
Chaikin MF (20)0.14
Today vs 20d5.08×
Avg vol (14d)3.85M
Avg vol (20d)3.52M
Avg $ vol (20d)8.26M
Market cap1.07B
RS 3m (vs SPY)+41.33%
RS 6m (vs SPY)+95.21%
RS line new highNo
Trend template8/8
Technical rank85.6
1 week+3.00%
1 month+8.11%
3 months+20.00%
6 months+95.12%
1 year+114.29%
YTD+110.53%
P/E-21.21
P/B6.12
P/S177.95
P/FCF-15.74
EPS-0.1400
Div yield—
ROE-28.84%
ROA-20.13%
Debt/Eq0.29
Current13.37
EV/EBITDA-22.33
Gross margin—
Net margin-838.88%
Rev growth440.63%
EPS growth74.88%
Price target5.03
Target upside109.58%
Analyst ratingBuy
Institutional79.35%
Ent. value1.08B
Revenue1.26M
Net income-31.77M
Gross profit—
Free cash flow-67.85M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out444.2M
Employees81
ListedFri, Apr 7, 2000
Free float158.98M
Float %43.7%
Short interest32.73M
Days to cover12.0d
Short volume61.0%
Squeeze score94 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.06 vs −$0.06
Last surprise0.0% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank85.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.60
Support2.00
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LXRX
No recent disclosed trades by Congress in LXRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in LXRX · 6 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BARKER SAM L Director · Restricted Stock Units · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
BARKER SAM L Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
DEBBANE RAYMOND Director · Common Stock · 2026-06-03 | Other | — | — | 2026-06-03 | 2026-06-04 |
SOBECKI CHRISTOPHER J Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
Amouyal Philippe Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
SOBECKI CHRISTOPHER J Director · Restricted Stock Units · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
Sullivan Diane E. Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
Amouyal Philippe Director · Restricted Stock Units · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
DEBBANE RAYMOND Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
Swain Judith L Director · Common Stock · 2026-06-03 | Exercise | 89.31K | $0 | 2026-06-03 | 2026-06-04 |
SEC filings
EDGAR filings in LXRX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.